TNF Pharmaceuticals Inc (NASDAQ:TNFA) has a beta value of 2.07 and has seen 3.65 million shares traded in the last trading session. The TNFA stock price is -1442.86% off its 52-week high price of $2.16 and 7.14% above the 52-week low of $0.13. If we look at the company’s 10-day average daily trading volume, we find that it stood at 12.69 million shares traded. The 3-month trading volume is 4.21 million shares.

TNF Pharmaceuticals Inc (NASDAQ:TNFA) trade information

Sporting -1.08%% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the TNFA stock price touched $0.14 or saw a rise of 9.15%. Year-to-date, TNF Pharmaceuticals Inc shares have moved -93.46%, while the 5-day performance has seen it change 0.73%. Over the past 30 days, the shares of TNF Pharmaceuticals Inc (NASDAQ:TNFA) have changed -10.27%. Short interest in the company has seen 2.13 million shares shorted with days to cover at 0.75.

TNF Pharmaceuticals Inc (TNFA) estimates and forecasts

The company’s shares have lost -88.78% over the past 6 months.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 50.65% over the past 5 years.

TNFA Dividends

TNF Pharmaceuticals Inc is expected to release its next earnings report in July this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

TNF Pharmaceuticals Inc (NASDAQ:TNFA)’s Major holders

Insiders own 0.11% of the company shares, while shares held by institutions stand at 3.43% with a share float percentage of 3.44%. Investors are also buoyed by the number of investors in a company, with TNF Pharmaceuticals Inc having a total of 28.0 institutions that hold shares in the company.